corona
The SARS-CoV-2 B.1.1.7 lineage
A note on the coronavirus variant B.1.1.7, which has first been described in the U.K. and has spread to 57 countries. The note summarises…
Cell under attack
It’s almost a year since the coronavirus outbreak was declared a pandemic, affecting all our lives. While the virus continues its grip on the…
Replication cycle of SARS-CoV-2 in 3D
Researchers have studied SARS-CoV-2 replication in cells and obtained detailed insights into the alterations induced in infected cells. This…
Repurposing drugs for a pan-coronavirus treatment
Scientists from the Beltrao Group at EMBL-EBI and collaborators identified drug targets common to SARS-CoV-2, SARS-CoV-1, and MERS-CoV, three…
Remote access to EMBL structural biology pipelines to support research on SARS-CoV-2
The Marquez Team has restarted operations at the High-Throughput Crystallisation (HTX) lab at EMBL Grenoble. The team has developed a fully automated…
Why share data during a pandemic?
In March 2020, planes were grounded, streets went quiet, and our lives changed forever. But while the world came to a halt, many scientists were…
EMBL-EBI launches COVID-19 Data Portal
The new collaborative space will help scientists, public health and healthcare professionals around the world to fight the coronavirus…
Last 6 months:
- April 2021 (9)
- March 2021 (17)
- February 2021 (23)
- January 2021 (17)
- December 2020 (18)
- November 2020 (12)
By year:
By topics:
- Alumni (101)
- Events (162)
- Lab Matters (399)
- Picture of the week (102)
- Science (704)
EMBLetc.
Read the latest Issues of our magazine - EMBLetc.
Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.
EMBLetc. archive